Compare ATLCP & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Atlanticus Holdings Corporation 7.625% Series B Cumulative Perpetual Preferred Stock no par value per share
Current Price
| Metric | ATLCP | CADL |
|---|---|---|
| Founded | N/A | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 1.0B |
| IPO Year | 2009 | 2021 |
| Metric | ATLCP | CADL |
|---|---|---|
| Price | $24.20 | $10.87 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $19.00 |
| AVG Volume (30 Days) | 3.5K | ★ 1.1M |
| Earning Date | N/A | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.95 | ★ 58.62 |
| EPS | ★ 4.74 | N/A |
| Revenue | ★ $1,968,399,000.00 | $125,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $5.04 | ★ N/A |
| Revenue Growth | ★ 50.09 | N/A |
| 52 Week Low | $20.46 | $4.35 |
| 52 Week High | $25.00 | $14.00 |
| Indicator | ATLCP | CADL |
|---|---|---|
| Relative Strength Index (RSI) | 52.65 | 41.77 |
| Support Level | $23.71 | $9.40 |
| Resistance Level | $24.35 | $11.36 |
| Average True Range (ATR) | 0.28 | 0.69 |
| MACD | 0.02 | -0.28 |
| Stochastic Oscillator | 85.07 | 27.99 |
Atlanticus Holdings Corp is a financial technology company powering more inclusive financial solutions for Everyday Americans. It provides technology and other support services to lenders who offer an array of financial products and services to consumers. The company's products and services are reported through two reportable segments. Credit as a Service (CaaS) offers products including private label credit cards using the Fortiva and Curae brand names as well as merchant-associated brands and Auto Finance provides purchase and/or service loans secured by automobiles from or for, and also provides floor-plan financing for, a pre-qualified network of independent automotive dealers and automotive finance companies in the buy-here, pay-here used car business.
Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.